The angiotensin receptor blocker, candesartan reduces atherosclerosis in a dose-dependent manner

被引:0
|
作者
Johnstone, MT [1 ]
Perez, A [1 ]
Stewart, R [1 ]
Cole, D [1 ]
Weissberg, J [1 ]
Quist, W [1 ]
机构
[1] Harvard Univ, Sch Med, Beth Israel Deaconess Med Ctr, Boston, MA USA
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:294A / 294A
页数:1
相关论文
共 50 条
  • [31] The angiotensin II type 1 receptor blocker candesartan attenuates graft vasculopathy
    Yamamoto, T
    Fukuda, D
    Takamoto, S
    CIRCULATION, 2005, 112 (17) : U263 - U263
  • [32] Effect of the angiotensin II type 1 receptor blocker candesartan on cardiovascular events
    Kondo, J
    Sone, T
    Tsuboi, H
    Mukawa, H
    Morishima, I
    Uesugi, M
    Kosaka, T
    Yoshida, T
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2002, 39 (05) : 320A - 320A
  • [33] Effect of the angiotensin II receptor blocker candesartan on fibrinolysis in patients with mild hypertension
    Skurk, T
    Lee, YM
    Nicuta-Rölfs, TO
    Haastert, B
    Wirth, A
    Hauner, H
    DIABETES OBESITY & METABOLISM, 2004, 6 (01): : 56 - 62
  • [34] The angiotensin I type 1 receptor blocker candesartan attenuates graft vasculopathy
    Yamamoto, T
    Sata, M
    Fukuda, D
    Takamoto, S
    JOURNAL OF SURGICAL RESEARCH, 2006, 132 (01) : 62 - 68
  • [35] Pleiotropic Benefits of the Angiotensin Receptor Blocker Candesartan in a Mouse Model of Alzheimer Disease
    Trigiani, Lianne J.
    Royea, Jessika
    Lacalle-Aurioles, Maria
    Tong, Xin-Kang
    Hamel, Edith
    HYPERTENSION, 2018, 72 (05) : 1217 - 1226
  • [36] Effects of low-dose angiotensin II receptor blocker candesartan on cardiovascular events in patients with coronary artery disease
    Kondo, J
    Sone, T
    Tsuboi, H
    Mukawa, H
    Morishima, I
    Uesugi, M
    Kona, T
    Kosaka, T
    Yoshida, T
    Numaguchi, Y
    Matsui, H
    Murohara, T
    Okumura, K
    AMERICAN HEART JOURNAL, 2003, 146 (06)
  • [37] Erythropoietin reduces necrosis in critically ischemic myocutaneous tissue by protecting nutritive perfusion in a dose-dependent manner
    Harder, Yves
    Amon, Michaela
    Schramm, Rene
    Contaldo, Claudio
    Metzkow, Eva
    Matzen, Anne
    Ruecker, Martin
    Vollmar, Brigitte
    Menger, Michael D.
    SURGERY, 2009, 145 (04) : 372 - 383
  • [38] REMIFENTANIL REDUCES AUDITORY AND SOMATOSENSORY-EVOKED RESPONSES DURING ISOFLURANE ANESTHESIA IN A DOSE-DEPENDENT MANNER
    NEWTON, DEF
    THORNTON, C
    CRABB, IJ
    KONIECZKO, KM
    JORDAN, C
    BRITISH JOURNAL OF ANAESTHESIA, 1994, 73 (05) : P720 - P720
  • [39] A spectrum of exercise training reduces soluble Aβ in a dose-dependent manner in a mouse model of Alzheimer's disease
    Moore, Kaitlin M.
    Girens, Renee E.
    Larson, Sara K.
    Jones, Maria R.
    Restivo, Jessica L.
    Holtzman, David M.
    Cirrito, John R.
    Yuede, Carla M.
    Zimmerman, Scott D.
    Timson, Benjamin F.
    NEUROBIOLOGY OF DISEASE, 2016, 85 : 218 - 224
  • [40] Candesartan, an angiotensin II type-1 receptor blocker, reduces cardiovascular events in patients on chronic haemodialysis - a randomized study
    Takahashi, Akihiko
    Takase, Hiroyuki
    Toriyama, Takayuki
    Sugiura, Tomonori
    Kurita, Yutaka
    Ueda, Ryuzo
    Dohi, Yasuaki
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2006, 21 (09) : 2507 - 2512